Viking Therapeutics launches oral maintenance dosing trial of obesity drug VK2735
Viking Therapeutics has initiated an exploratory trial for oral maintenance dosing of its obesity drug candidate VK2735. This new phase follows initial weight loss observed from injections. The trial will assess whether oral tablets or less frequent injections can sustain weight loss, while monitoring safety and drug e